TW200505415A - Composition for improving immunity of animals - Google Patents

Composition for improving immunity of animals

Info

Publication number
TW200505415A
TW200505415A TW093103960A TW93103960A TW200505415A TW 200505415 A TW200505415 A TW 200505415A TW 093103960 A TW093103960 A TW 093103960A TW 93103960 A TW93103960 A TW 93103960A TW 200505415 A TW200505415 A TW 200505415A
Authority
TW
Taiwan
Prior art keywords
animals
composition
improving immunity
salt
cysteamine
Prior art date
Application number
TW093103960A
Other languages
English (en)
Inventor
Francis Chi
Qin-Tang Wen
Original Assignee
Walcom Animal Science I P 6 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walcom Animal Science I P 6 Ltd filed Critical Walcom Animal Science I P 6 Ltd
Publication of TW200505415A publication Critical patent/TW200505415A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/131Amines acyclic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/105Aliphatic or alicyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
TW093103960A 2003-02-19 2004-02-18 Composition for improving immunity of animals TW200505415A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0303843A GB2398497A (en) 2003-02-19 2003-02-19 Composition for improving immunity of animals

Publications (1)

Publication Number Publication Date
TW200505415A true TW200505415A (en) 2005-02-16

Family

ID=9953321

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093103960A TW200505415A (en) 2003-02-19 2004-02-18 Composition for improving immunity of animals

Country Status (9)

Country Link
US (1) US20060140906A1 (zh)
EP (1) EP1594487A1 (zh)
JP (1) JP2006517942A (zh)
KR (1) KR20050102130A (zh)
CN (1) CN1750816A (zh)
AR (1) AR043717A1 (zh)
GB (1) GB2398497A (zh)
TW (1) TW200505415A (zh)
WO (1) WO2004073700A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200528090A (en) * 2004-01-13 2005-09-01 Omega Bio Pharma I P 2 Ltd Methods for treating stress and affecting biological immune systems
EP1744737A2 (en) 2004-05-03 2007-01-24 Omega Bio-Pharma (I.P.3) Limited Cysteamines for treating complications of hypercholesterolemia and diabetes
CN100434118C (zh) * 2005-09-27 2008-11-19 上海华扩达生化科技有限公司 半胱胺及其衍生物在制备提高疫苗抗体效价药物中的应用
AR057623A1 (es) * 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales
EP1919458B3 (en) 2006-01-27 2017-01-11 The Regents of The University of California Enterically coated cysteamine, cystamine and derivatives thereof
PL2214480T3 (pl) * 2007-11-30 2013-11-29 Univ California Sposoby leczenia niealkoholowego stłuszczającego zapalenia wątroby (NASH) przy użyciu produktów cysteaminowych
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
WO2010138419A2 (en) * 2009-05-23 2010-12-02 Obio Pharmaceutical (H.K.) Ltd. Materials and methods for treating viral infections
GB201021186D0 (en) 2010-12-14 2011-01-26 Novabiotics Ltd Composition
TWI649100B (zh) 2013-06-17 2019-02-01 地平線罕見醫學製藥有限責任公司 延遲釋放型半胱胺珠粒調配物,以及其製備及使用方法
US10537528B2 (en) 2015-11-16 2020-01-21 The Regents Of The University Of California Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds
US10143665B2 (en) 2015-11-17 2018-12-04 Horizon Orphan Llc Methods for storing cysteamine formulations and related methods of treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055560B (it) * 1974-05-02 1982-01-11 Istituto Chemioterapico Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali
US4657932A (en) * 1982-05-06 1987-04-14 Massachusetts General Hospital Method of treating prolactin-related disorders
US4711897A (en) * 1985-04-24 1987-12-08 Smithkline Beckman Corporation Animal feed methods and compositions using cysteamine
US5605885A (en) * 1988-05-05 1997-02-25 Entremed, Inc. Method for stimulating the immune system
DE4305788C2 (de) * 1993-02-25 1997-06-12 Beiersdorf Ag Kosmetische und dermatologische Formulierungen zum Schutze der Haut gegen Oxidationsprozesse
DK0656773T3 (da) * 1992-08-26 1997-10-13 Univ Leiden Anvendelse af radikalfangere som immunmodulerende agenser i kosmetiske og dermatologiske tilberedninger.
FR2716625B1 (fr) * 1994-02-25 1996-04-26 Gouchet Franck Arno Préparation et utilisation de formes pharmaceutiques et cosmétiques contenant des composés d'inclusion avec les cyclodextrines de cystéamine, sels de cystéamine, ou dérivés de la cystéamine, sous forme de sel ou non.
EP0858327A2 (en) * 1995-09-25 1998-08-19 Samir Chachoua Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
EP0951841A1 (en) * 1997-12-23 1999-10-27 Societe Des Produits Nestle S.A. Process for the preparation of flavouring compositions and use of these compositions in bakery products
US6380248B1 (en) * 1998-02-04 2002-04-30 Winthrop University Hospital Metal-thiols as immunomodulating agents
MXPA01010933A (es) * 1999-04-29 2002-06-21 Merck Patent Gmbh Inhibidores del sistema de clivaje de la glicina como potenciales antipsicoticos.
AU2001294458B2 (en) * 2000-10-06 2004-03-11 Jagotec Ag Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
CN1144585C (zh) * 2000-12-13 2004-04-07 华扩达动物科学[I.P.2]有限公司 含有半胱胺或其盐类的促进动物快速生长的组合物及用途
GB2377874B (en) * 2001-07-23 2005-06-22 Walcom Bio Chemicals Ind Ltd Poultry feed and the use thereof

Also Published As

Publication number Publication date
WO2004073700A1 (en) 2004-09-02
JP2006517942A (ja) 2006-08-03
US20060140906A1 (en) 2006-06-29
GB0303843D0 (en) 2003-03-26
EP1594487A1 (en) 2005-11-16
KR20050102130A (ko) 2005-10-25
GB2398497A (en) 2004-08-25
AR043717A1 (es) 2005-08-10
CN1750816A (zh) 2006-03-22

Similar Documents

Publication Publication Date Title
HK1094421A1 (en) (S)-2-n-propylamino-5-hydroxytetralin as a d3-agonist
HK1079522A1 (en) Thienyl compounds
SG145694A1 (en) Novel compounds
CR7076S (es) Recipiente
DE60112974D1 (en) Carbolinderivate
IL165584A0 (en) Novel formate salt of o-desmethyl-venlafaxine
TR200700263T1 (tr) Diş fırçaları ve bunları yapmak ve kullanmak içinyöntemler
HK1077059A1 (en) Salt of (s)-pantoprazole and its hydrates (s)-
TW200505415A (en) Composition for improving immunity of animals
DE60216233D1 (en) Carbolinderivate
RS98704A (en) New pharmaceutical compositions containing flibanserin polymorpha
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
HK1068274A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
SG139747A1 (en) Inhibitors of the mutant form of kit
HRP20050611B1 (hr) Kombinacijski lijek
ATE383851T1 (de) Zusammensetzung mit cysteamin zur verbesserung der laktation von milchvieh
GB0212410D0 (en) Organic compounds
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
BRPI0408446A (pt) tablete de limpeza
TW200420561A (en) Antimicrobial 1-aryl dihydropyridone compounds
PL358996A1 (en) Permanent water-base composition for making, the method of its manufacture as well as the appliance containing this composition for waste-base marking
GEP20084546B (en) Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
EP1684794A4 (en) ALTERATION OF COMPOSITION OF ANIMAL WASTE